CAL

Capital Analysts LLC Portfolio holdings

AUM $3B
1-Year Return 13.22%
This Quarter Return
-15.2%
1 Year Return
+13.22%
3 Year Return
+43.77%
5 Year Return
+72.11%
10 Year Return
+142.18%
AUM
$815M
AUM Growth
-$197M
Cap. Flow
-$18.1M
Cap. Flow %
-2.23%
Top 10 Hldgs %
42.66%
Holding
765
New
45
Increased
213
Reduced
221
Closed
86
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ELS icon
326
Equity Lifestyle Properties
ELS
$12B
$54K 0.01%
935
+2
+0.2% +$116
WY icon
327
Weyerhaeuser
WY
$18.9B
$54K 0.01%
3,174
+42
+1% +$715
SBNY
328
DELISTED
Signature Bank
SBNY
$54K 0.01%
672
+42
+7% +$3.38K
ADC icon
329
Agree Realty
ADC
$8.08B
$53K 0.01%
863
+4
+0.5% +$246
DLR icon
330
Digital Realty Trust
DLR
$55.7B
$53K 0.01%
380
+4
+1% +$558
LNC icon
331
Lincoln National
LNC
$7.98B
$53K 0.01%
2,015
+823
+69% +$21.6K
SYY icon
332
Sysco
SYY
$39.4B
$52K 0.01%
1,135
-412
-27% -$18.9K
NVR icon
333
NVR
NVR
$23.5B
$51K 0.01%
20
SPGI icon
334
S&P Global
SPGI
$164B
$51K 0.01%
208
WTRE icon
335
WisdomTree New Economy Real Estate Fund
WTRE
$14.1M
$51K 0.01%
2,300
YUMC icon
336
Yum China
YUMC
$16.5B
$51K 0.01%
1,189
-163
-12% -$6.99K
BXP icon
337
Boston Properties
BXP
$12.2B
$50K 0.01%
544
+2
+0.4% +$184
LUV icon
338
Southwest Airlines
LUV
$16.5B
$50K 0.01%
1,413
BIO icon
339
Bio-Rad Laboratories Class A
BIO
$8B
$49K 0.01%
139
-41
-23% -$14.5K
ED icon
340
Consolidated Edison
ED
$35.4B
$49K 0.01%
626
FFIV icon
341
F5
FFIV
$18.1B
$48K 0.01%
453
RPG icon
342
Invesco S&P 500 Pure Growth ETF
RPG
$1.72B
$48K 0.01%
2,410
-11,090
-82% -$221K
XEL icon
343
Xcel Energy
XEL
$43B
$48K 0.01%
800
VAR
344
DELISTED
Varian Medical Systems, Inc.
VAR
$48K 0.01%
465
AVB icon
345
AvalonBay Communities
AVB
$27.8B
$47K 0.01%
318
+1
+0.3% +$148
WELL icon
346
Welltower
WELL
$112B
$47K 0.01%
1,029
-16,498
-94% -$754K
RDS.B
347
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$47K 0.01%
+1,440
New +$47K
APTV icon
348
Aptiv
APTV
$17.5B
$46K 0.01%
935
FTLS icon
349
First Trust Long/Short Equity ETF
FTLS
$1.97B
$46K 0.01%
1,225
+480
+64% +$18K
NVS icon
350
Novartis
NVS
$251B
$46K 0.01%
553